How should I evaluate and manage an 85-year-old woman with severe anemia, low red blood cell count, macrocytosis, and elevated red cell distribution width (RDW), with otherwise normal complete blood count (CBC)?

Evaluation and Management of Severe Anemia in an 85-Year-Old Woman

This patient requires immediate peripheral blood smear review, reticulocyte count, vitamin B12/folate levels, iron studies (ferritin, transferrin saturation), and assessment for occult blood loss, with consideration for transfusion given the severe anemia (Hgb 7.6 g/dL) and advanced age. 1

Initial Assessment Priority

Assess for symptoms requiring immediate transfusion. At age 85 with hemoglobin of 7.6 g/dL, evaluate for syncope, exercise dyspnea, chest pain, vertigo, or significant cardiovascular/pulmonary comorbidities that would necessitate packed red blood cell (PRBC) transfusion before completing the diagnostic workup 1. Even asymptomatic elderly patients with significant comorbidities should be considered for transfusion at this hemoglobin level 1.

Morphologic Classification

The MCV of 96.1 fL places this patient at the upper limit of normocytic anemia, approaching macrocytosis (>100 fL) 1. The elevated RDW of 17.3 indicates significant red cell size heterogeneity, which is particularly important as it suggests either:

• Mixed deficiency states (iron deficiency coexisting with B12/folate deficiency) 1
• Early macrocytic anemia with concurrent microcytic process 1
• Myelodysplastic syndrome (MDS), especially critical in this age group 1, 2

The combination of borderline-high MCV with elevated RDW in an elderly patient carries significant prognostic implications, with studies showing multiplicative mortality risk when both are present 3.

Essential Diagnostic Workup

Minimum Required Tests 1:

• Peripheral blood smear - Critical to confirm RBC morphology and identify dysplastic features 1
• Reticulocyte count/index - Distinguishes hypoproliferative (low reticulocytes) from hemolytic/hemorrhagic causes (high reticulocytes) 1
• Vitamin B12 and folate levels - Macrocytosis most commonly indicates megaloblastic anemia from B12/folate deficiency 1
• Iron studies: serum ferritin and transferrin saturation - Ferritin <30 ng/mL indicates iron deficiency; transferrin saturation <15% confirms absolute iron deficiency 1
• Stool guaiac or fecal occult blood testing - Essential in elderly patients to identify GI blood loss 1

Extended Workup if Initial Tests Inconclusive 1:

• Haptoglobin, lactate dehydrogenase, indirect bilirubin (for hemolysis) 1
• Creatinine and estimated GFR (renal insufficiency causes normocytic anemia) 1
• Thyroid function tests (hypothyroidism causes macrocytosis) 1, 2
• C-reactive protein (inflammation marker) 1

Differential Diagnosis Based on Laboratory Pattern

Most Likely Causes in This Patient:

1. Vitamin B12 or Folate Deficiency 1

• MCV approaching macrocytic range strongly suggests megaloblastic anemia
• Pernicious anemia is common in elderly patients
• Important caveat: 31-35% of untreated pernicious anemia patients have normal RDW, and 35% have normal MCV 4

2. Myelodysplastic Syndrome (MDS) 1, 2

• Critical consideration in patients >65 years with unexplained anemia
• 54.7% of MDS patients present with macrocytic anemia 5
• 84.7% of MDS patients have elevated RDW 5
• Requires hematology consultation if suspected, especially with other cytopenias 1, 2

3. Mixed Deficiency (Iron + B12/Folate) 1

• High RDW with borderline-normal MCV suggests coexisting microcytic and macrocytic processes
• The two deficiencies can "neutralize" each other's effect on MCV 1

4. Anemia of Chronic Disease 1

• Can present as normocytic or mildly macrocytic
• Check for underlying malignancy, chronic infection, or inflammatory conditions

5. Chronic Kidney Disease 1

• Typically normocytic with inappropriately low reticulocytes
• Check creatinine and GFR 1

Kinetic Approach: Reticulocyte Index Interpretation

If Reticulocyte Index <1.0-2.0 (Low) 1:

• Indicates decreased RBC production
• Suggests: iron deficiency, B12/folate deficiency, bone marrow failure, MDS, or chronic disease 1

If Reticulocyte Index >2.0 (High) 1:

• Indicates normal/increased RBC production
• Suggests: acute blood loss or hemolysis
• Pursue hemolysis workup (haptoglobin, LDH, Coombs test) 1

Management Algorithm

Immediate Management:

1. Consider PRBC transfusion if symptomatic or high-risk comorbidities present 1
   • Each unit increases Hgb by approximately 1 g/dL 1
   • Do not base decision solely on hemoglobin threshold; assess individual patient factors 1

Cause-Specific Treatment Once Diagnosed:

For B12/Folate Deficiency 1:

• Initiate appropriate vitamin replacement
• B12 deficiency: intramuscular or high-dose oral B12
• Folate deficiency: oral folic acid supplementation

For Iron Deficiency 1:

• Oral or intravenous iron supplementation
• Investigate and treat source of blood loss
• Goal: normalize hemoglobin and replete iron stores 1

For MDS 1:

• Hematology referral mandatory
• May require erythropoiesis-stimulating agents (ESAs) if serum EPO <200 U/L 1
• Consider lenalidomide if del(5q) present 1
• Allogeneic stem cell transplant for eligible patients 1

Critical Pitfalls to Avoid

• Do not assume anemia is "normal aging" - underlying causes must be identified and treated 6
• Do not overlook MDS in elderly patients with unexplained macrocytic anemia, especially with other cytopenias 1, 2
• Do not rely solely on MCV - elevated RDW can indicate mixed deficiencies even with normal MCV 1
• Do not miss occult GI bleeding - essential to check stool for blood in elderly patients with iron deficiency 1
• Do not delay hematology consultation if cause remains unclear after initial workup or if MDS suspected 1, 2

Prognostic Considerations

The combination of elevated RDW (17.3) with borderline macrocytosis in an elderly patient carries significant mortality risk (HR 5.22-7.76 in non-anemic patients with both findings) 3. This underscores the importance of thorough evaluation and aggressive management in this 85-year-old patient 3.